Ultragenyx Pharmaceutical Inc (OQ:RARE)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for RARE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 17th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 17/19 Sep 16/19 Sharp Shalini Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -24,880  
Sep 17/19 Sep 16/19 Sharp Shalini Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,963  
Sep 17/19 Sep 16/19 Sharp Shalini Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 24,880 $6.86
Sep 17/19 Sep 16/19 Sharp Shalini Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,963 $0.810
Sep 11/19 Sep 11/19 Kakkis Emil D Direct Ownership Common Stock P - Open market or private purchase 5,000 $43.63
Jul 17/19 Jul 16/19 Pinion John Richard Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -649 $59.17
Jul 9/19 Jul 6/19 Harris Erik Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -260 $59.51
Jun 24/19 Jun 24/19 Parschauer Karah Herdman Direct Ownership Common Stock S - Open market or private sale -1,226 $61.50
Jun 24/19 Jun 21/19 Parschauer Karah Herdman Direct Ownership Common Stock S - Open market or private sale -1,489 $63.01
Jun 21/19 Jun 21/19 Harris Erik Direct Ownership Stock Option (Right to Buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for RARE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 17th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 17/19 Sep 16/19 Sharp Shalini Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -24,880  
Sep 17/19 Sep 16/19 Sharp Shalini Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,963  
Sep 17/19 Sep 16/19 Sharp Shalini Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 24,880 $6.86
Sep 17/19 Sep 16/19 Sharp Shalini Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,963 $0.810
Sep 11/19 Sep 11/19 Kakkis Emil D Direct Ownership Common Stock P - Open market or private purchase 5,000 $43.63
Jul 17/19 Jul 16/19 Pinion John Richard Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -649 $59.17
Jul 9/19 Jul 6/19 Harris Erik Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -260 $59.51
Jun 24/19 Jun 24/19 Parschauer Karah Herdman Direct Ownership Common Stock S - Open market or private sale -1,226 $61.50
Jun 24/19 Jun 21/19 Parschauer Karah Herdman Direct Ownership Common Stock S - Open market or private sale -1,489 $63.01
Jun 24/19 Jun 20/19 Parschauer Karah Herdman Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -649 $63.48
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $RARE

StockTwits